Investors

Analyst Coverage

  • Edward Nash

    Canaccord Genuity
    • Michael Morabito

      Chardan
      • Joel Beatty

        Citi
        • Ritu Baral

          Cowen
          • Josh Schimmer M.D.

            Evercore ISI
            • Salveen Richter

              Goldman Sachs
              • Ed Arce

                HC Wainwright
                • Liisa Bayko

                  JMP Securities
                  • Jay Olson

                    Oppenheimer
                    • Steve Seedhouse

                      Raymond James & Associates
                      • Mayank Mamtani

                        B Riley FBR
                        • Yasmeen Rahimi

                          Roth Capital Partners
                          • Derek Archila

                            Stifel
                            • Thomas Smith

                              SVB Leerink
                              • Navin Jacob

                                UBS
                                • Akash Tewari

                                  Wolfe Research

                                  Madrigal Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Madrigal Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Madrigal Pharmaceuticals, Inc. or its management. Madrigal Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.